These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 33781887)
1. Curcumin encapsulation in nanostructures for cancer therapy: A 10-year overview. D'Angelo NA; Noronha MA; Kurnik IS; Câmara MCC; Vieira JM; Abrunhosa L; Martins JT; Alves TFR; Tundisi LL; Ataide JA; Costa JSR; Jozala AF; Nascimento LO; Mazzola PG; Chaud MV; Vicente AA; Lopes AM Int J Pharm; 2021 Jul; 604():120534. PubMed ID: 33781887 [TBL] [Abstract][Full Text] [Related]
2. Advances in nanotechnology-based delivery systems for curcumin. Sun M; Su X; Ding B; He X; Liu X; Yu A; Lou H; Zhai G Nanomedicine (Lond); 2012 Jul; 7(7):1085-100. PubMed ID: 22846093 [TBL] [Abstract][Full Text] [Related]
3. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Naksuriya O; Okonogi S; Schiffelers RM; Hennink WE Biomaterials; 2014 Mar; 35(10):3365-83. PubMed ID: 24439402 [TBL] [Abstract][Full Text] [Related]
4. Curcumin Based Drug Delivery Systems for Cancer Therapy. Tiwari A; Jain SK Curr Pharm Des; 2020; 26(42):5430-5440. PubMed ID: 32348207 [TBL] [Abstract][Full Text] [Related]
5. Recent progress in studying curcumin and its nano-preparations for cancer therapy. Liu J; Chen S; Lv L; Song L; Guo S; Huang S Curr Pharm Des; 2013; 19(11):1974-93. PubMed ID: 23116308 [TBL] [Abstract][Full Text] [Related]
6. Recent advances in colloidal delivery systems for nutraceuticals: A case study - Delivery by Design of curcumin. Kharat M; McClements DJ J Colloid Interface Sci; 2019 Dec; 557():506-518. PubMed ID: 31542691 [TBL] [Abstract][Full Text] [Related]
7. An updated and comprehensive review on the potential health effects of curcumin-encapsulated micro/nanoparticles. Rashwan AK; Karim N; Xu Y; Hanafy NAN; Li B; Mehanni AE; Taha EM; Chen W Crit Rev Food Sci Nutr; 2023; 63(29):9731-9751. PubMed ID: 35522080 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization and anti-cancer activity of Pluronic F68-curcumin conjugate micelles. Cai Y; Sun Z; Fang X; Fang X; Xiao F; Wang Y; Chen M Drug Deliv; 2016 Sep; 23(7):2587-2595. PubMed ID: 26066393 [TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical strategies of improving oral systemic bioavailability of curcumin for clinical application. Ma Z; Wang N; He H; Tang X J Control Release; 2019 Dec; 316():359-380. PubMed ID: 31682912 [TBL] [Abstract][Full Text] [Related]
10. Doxorubicin nanoformulations on therapy against cancer: An overview from the last 10 years. D'Angelo NA; Noronha MA; Câmara MCC; Kurnik IS; Feng C; Araujo VHS; Santos JHPM; Feitosa V; Molino JVD; Rangel-Yagui CO; Chorilli M; Ho EA; Lopes AM Biomater Adv; 2022 Feb; 133():112623. PubMed ID: 35525766 [TBL] [Abstract][Full Text] [Related]
11. Drug induced micellization into ultra-high capacity and stable curcumin nanoformulations: Physico-chemical characterization and evaluation in 2D and 3D in vitro models. Lübtow MM; Nelke LC; Seifert J; Kühnemundt J; Sahay G; Dandekar G; Nietzer SL; Luxenhofer R J Control Release; 2019 Jun; 303():162-180. PubMed ID: 30981815 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxic, Genotoxic and Senolytic Potential of Native and Micellar Curcumin. Beltzig L; Frumkina A; Schwarzenbach C; Kaina B Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371895 [TBL] [Abstract][Full Text] [Related]
13. Liposomal curcumin and its application in cancer. Feng T; Wei Y; Lee RJ; Zhao L Int J Nanomedicine; 2017; 12():6027-6044. PubMed ID: 28860764 [TBL] [Abstract][Full Text] [Related]
14. Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells. Patil S; Choudhary B; Rathore A; Roy K; Mahadik K Phytomedicine; 2015 Nov; 22(12):1103-11. PubMed ID: 26547533 [TBL] [Abstract][Full Text] [Related]
15. Potential Role of Curcumin and Its Nanoformulations to Treat Various Types of Cancers. Kabir MT; Rahman MH; Akter R; Behl T; Kaushik D; Mittal V; Pandey P; Akhtar MF; Saleem A; Albadrani GM; Kamel M; Khalifa SAM; El-Seedi HR; Abdel-Daim MM Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33800000 [TBL] [Abstract][Full Text] [Related]
16. Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin. Mohanty C; Das M; Sahoo SK Expert Opin Drug Deliv; 2012 Nov; 9(11):1347-64. PubMed ID: 22971222 [TBL] [Abstract][Full Text] [Related]
17. The bioavailability, metabolism and microbial modulation of curcumin-loaded nanodelivery systems. Chang R; Chen L; Qamar M; Wen Y; Li L; Zhang J; Li X; Assadpour E; Esatbeyoglu T; Kharazmi MS; Li Y; Jafari SM Adv Colloid Interface Sci; 2023 Aug; 318():102933. PubMed ID: 37301064 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial Activity of Curcumin in Nanoformulations: A Comprehensive Review. Trigo-Gutierrez JK; Vega-Chacón Y; Soares AB; Mima EGO Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281181 [TBL] [Abstract][Full Text] [Related]
19. Curcumin-loaded self-nanomicellizing solid dispersion system: part I: development, optimization, characterization, and oral bioavailability. Parikh A; Kathawala K; Song Y; Zhou XF; Garg S Drug Deliv Transl Res; 2018 Oct; 8(5):1389-1405. PubMed ID: 29845380 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of Biological and Pharmacological Properties of an Encapsulated Polyphenol: Curcumin. Witika BA; Makoni PA; Matafwali SK; Mweetwa LL; Shandele GC; Walker RB Molecules; 2021 Jul; 26(14):. PubMed ID: 34299519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]